Acanthamoeba: Difference between revisions
From IDWiki
Acanthamoeba
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
m (Aidan moved page Acanthamoeba species to Acanthamoeba without leaving a redirect) |
||
(4 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
==Background== |
==Background== |
||
===Microbiology=== |
===Microbiology=== |
||
* |
*One of the [[free-living amoebae]] |
||
* |
*Seventeen genotypes (T1-T17), of which 10 have caused disease in humans |
||
* |
*Most common is ''[[Acanthamoeba castellanii]]'' complex (T4) |
||
*Species traditionally organized morphologically into 3 groups |
|||
{| class="wikitable" |
|||
!Group |
|||
!Species |
|||
!Trophozoite Size |
|||
!Cyst Size |
|||
|- |
|||
|I |
|||
|''A. astronyxis'', ''A. comandoni'', ''A. tubiashi'', ''A. byersi'' |
|||
|30-125 μm |
|||
|16-35 μm |
|||
|- |
|||
|II |
|||
|''A. castellanii'', ''A. polyphaga'', ''A. rhysodes'', ''A. hatchetti'' |
|||
|15-45 μm |
|||
|≤18 μm |
|||
|- |
|||
|III |
|||
|''A. culbertsoni'', ''A. royreba'', ''A. lenticulata'' |
|||
|15-45 μm |
|||
|<18 μm with different morphologies |
|||
|} |
|||
===Life Cycle=== |
===Life Cycle=== |
||
* |
*Cysts and trophozoites can cause disease |
||
===Epidemiology=== |
===Epidemiology=== |
||
* |
*More common in immunocompromised patients, with risk factors including [[AIDS]], liver disease, diabetes, organ transplantation, corticosteroid use, chemotherapy, and rituximab |
||
==Clinical Manifestations== |
==Clinical Manifestations== |
||
===Granulomatous amebic encephalitis=== |
===Granulomatous amebic encephalitis=== |
||
* |
*Subacute presentation of encephalitis (fever, headache, nuchal rigidity, behaviour changes, altered level of conciousness, focal neurological deficiets) |
||
* |
*Often preceded by cutaneous lesions by months |
||
** |
**May include ulcers, nodules, and subcutaneous abscesses |
||
** |
**Amoebic granulomas on biopsy |
||
===Non-neurological disseminated acanthamoebiasis=== |
===Non-neurological disseminated acanthamoebiasis=== |
||
* |
*Rarely, patients may have disseminated disease without evidence of CNS involvement |
||
* |
*Mostly seen in patients with AIDS, transplant, or prolonged corticosteroid use |
||
* |
*Most commonly involves skin, but can involve liver, lungs, and bones |
||
===Amoebic keratitis=== |
===Amoebic keratitis=== |
||
* |
*Sight- and eye-threatening infection |
||
* |
*Often secondary to corneal trauma or improper contact lens hygiene |
||
* |
*Present with severe pain, photophobia, tearing |
||
* |
*May see dendiform epitheliopathy or stromal ring |
||
== Diagnosis == |
|||
* Ameba culture on nutrient agar with layer of gram-negative bacteria at 30ºC (cornea/skin) or 37–C (brain/lung) |
|||
* Species identification done with 18S rDNA sequencing |
|||
==Management== |
==Management== |
||
===Granulomatous amebic encephalitis=== |
===Granulomatous amebic encephalitis=== |
||
* |
*Can consider a combinaction of [[Is treated by::pentamidine]], [[Is treated by::azoles]], [[Is treated by::flucytosine]], [[Is treated by::sulfadiazine]], [[Is treated by::miltefosine]], [[Is treated by::amikacin]], and [[Is treated by::voriconazole]] |
||
===Amoebic keratitis=== |
===Amoebic keratitis=== |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
[[Category:Protozoa]] |
[[Category:Protozoa]] |
Latest revision as of 16:47, 25 January 2022
Background
Microbiology
- One of the free-living amoebae
- Seventeen genotypes (T1-T17), of which 10 have caused disease in humans
- Most common is Acanthamoeba castellanii complex (T4)
- Species traditionally organized morphologically into 3 groups
Group | Species | Trophozoite Size | Cyst Size |
---|---|---|---|
I | A. astronyxis, A. comandoni, A. tubiashi, A. byersi | 30-125 μm | 16-35 μm |
II | A. castellanii, A. polyphaga, A. rhysodes, A. hatchetti | 15-45 μm | ≤18 μm |
III | A. culbertsoni, A. royreba, A. lenticulata | 15-45 μm | <18 μm with different morphologies |
Life Cycle
- Cysts and trophozoites can cause disease
Epidemiology
- More common in immunocompromised patients, with risk factors including AIDS, liver disease, diabetes, organ transplantation, corticosteroid use, chemotherapy, and rituximab
Clinical Manifestations
Granulomatous amebic encephalitis
- Subacute presentation of encephalitis (fever, headache, nuchal rigidity, behaviour changes, altered level of conciousness, focal neurological deficiets)
- Often preceded by cutaneous lesions by months
- May include ulcers, nodules, and subcutaneous abscesses
- Amoebic granulomas on biopsy
Non-neurological disseminated acanthamoebiasis
- Rarely, patients may have disseminated disease without evidence of CNS involvement
- Mostly seen in patients with AIDS, transplant, or prolonged corticosteroid use
- Most commonly involves skin, but can involve liver, lungs, and bones
Amoebic keratitis
- Sight- and eye-threatening infection
- Often secondary to corneal trauma or improper contact lens hygiene
- Present with severe pain, photophobia, tearing
- May see dendiform epitheliopathy or stromal ring
Diagnosis
- Ameba culture on nutrient agar with layer of gram-negative bacteria at 30ºC (cornea/skin) or 37–C (brain/lung)
- Species identification done with 18S rDNA sequencing
Management
Granulomatous amebic encephalitis
- Can consider a combinaction of pentamidine, azoles, flucytosine, sulfadiazine, miltefosine, amikacin, and voriconazole
Amoebic keratitis
- Can be treated with any of:
- PHMB
- Chlorhexadine
- Topical and oral voriconazole
- Propamidine
- Hexamidine